Armistice Capital, LLC 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:05 pm Sale |
2024-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 6,400,000 4.470% |
-1,800,000 (-21.95%) |
Filing |
| 2024-11-14 4:47 pm Sale |
2024-09-30 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 8,200,000 5.730% |
-1,336,000 (-14.01%) |
Filing |
| 2024-02-14 3:27 pm Purchase |
2023-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 9,536,000 6.640% |
9,536,000 (New Position) |
Filing |